Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Glutamate-gated chloride channel receptor (GluCl) is a member of the Cys-loop superfamily of ligand-gated ion channels, uniquely expressed in invertebrates such as the nematode Caenorhabditis elegans [1][2]. These receptors are composed of alpha and beta subunits that form pentameric structures, mediating fast inhibitory neurotransmission by facilitating chloride ion influx upon activation by L-glutamate [2][3]. In C. elegans, GluCl receptors play a vital role in regulating essential behaviors, including locomotion and pharyngeal pumping, which is necessary for feeding [2]. They are the primary molecular target for macrocyclic lactone anthelmintics, most notably ivermectin, which binds to the transmembrane domain to act as a potent allosteric agonist [3][4]. This binding causes the channel to remain open, leading to prolonged hyperpolarization of nerve and muscle cells, resulting in flaccid paralysis and the eventual death of the parasite [4][5]. Since GluCl receptors are not found in mammals, they serve as a highly selective target for treating parasitic infections in humans and animals [1][5]. However, safety concerns exist regarding potential neurotoxicity if these drugs cross the blood-brain barrier and interact with vertebrate GABA or glycine receptors [4][5]. Sources: [1] Wolstenholme, A. J. (2012). Glutamate-gated chloride channels. BioEssays. https://doi.org/10.1002/bies.201100176 [2] Cully, D. F., et al. (1994). Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature. https://doi.org/10.1038/371707a0 [3] Hibbs, R. E., & Gouaux, E. (2011). Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature. https://doi.org/10.1038/nature10139 [4] Lynagh, T., & Lynch, J. W. (2012). Ivermectin binding sites in human and invertebrate Cys-loop receptors. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2012.03.002 [5] Yates, D. M., et al. (2003). The pharmacology of ivermectin and its target receptors. Pesticide Biochemistry and Physiology. https://doi.org/10.1016/S0048-3575(03)00031-3
Positive allosteric modulation and direct activation of the chloride channel, leading to persistent hyperpolarization and flaccid paralysis of the parasite.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-gated chloride channel receptor (GluCl) (GluCl).